Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 46 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
LabMed DDS from Oostkamp, company number BE0741659921, closed financial year 2025 with a result of € 547,081 after tax. For that financial year LabMed DDS recorded a gross margin of € 734,351 and equity of € 198,378. Compared with financial year 2024, the result moved from € 508,030 to € 547,081. Profitable, and profit is growing. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on June 22, 2026.
€ 198,378
▲ 96% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 547,081
▲ 8% vs 2024
Profit after tax over the fiscal year.
€ 113,435
▲ 92% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 450,000 paid out
82 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2025
€ 8,242
▼ 70% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 63,182
▲ € 56,170 vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 8,150
▲ 10% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 645,504 | € 573,174 | € 689,068 | € 734,351 | ▲ 7% |
| Profit after taxes | € 490,364 | € 419,168 | € 508,030 | € 547,081 | ▲ 8% |
| Equity | € 1,689,099 | € 108,267 | € 101,297 | € 198,378 | ▲ 96% |
| Total debts | € 28,587 | € 439,391 | € 358,220 | € 434,533 | ▲ 21% |
| Cash | € 605,835 | € 306,352 | € 58,952 | € 113,435 | ▲ 92% |
| Retained profit | € 1,688,979 | € 108,147 | € 101,177 | € 198,258 | ▲ 96% |
| Dividend | € 1,600 | € 2,000,000 | € 515,000 | € 450,000 | ▼ 13% |
| Balance sheet total | € 1,717,686 | € 547,658 | € 459,517 | € 632,911 | ▲ 38% |
Key figures of LabMed DDS, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to LabMed DDS?
What happened at LabMed DDS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 547,081 (▲ 8% vs 2024). Source: NBB ↗
- New establishment in Oostkamp. KBO
- Start of the company according to the CBE. KBO
- Dieter De Smet became a director. NBB
In short
From € 490,364 profit in 2022 to € 547,081 profit in 2025.
Paid € 657,009 in corporate taxes since 2022.
Best year ever: 2025, with € 547,081 profit.
Paid out € 3 million in dividends to the owners in total.
Management
Behind LabMed DDS is Dieter De Smet.
Directors
According to the 2025 annual accounts
Dieter De Smet
Director
since 2020
Establishments
Establishment units
Physical locations of this company
Kastanjedreef 8
8020 Oostkamp
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0741.659.921
- VAT number
- BE 0741.659.921
- Registered office
- Kastanjedreef 8, 8020 Oostkamp
- Names & denominations
- LabMed DDS
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 16 January 2020
- Peppol
- Active · Active since 19 Nov 2025
- Activities · NACE
Activiteiten van medisch specialisten
Activiteiten van holdings
Holdings